NEW YORK – BioMérieux is piloting advanced analytics software aimed at helping US hospitals curb antibiotic resistance and providing insights for their antimicrobial stewardship teams.

The software, unveiled last week at the American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California, is part of the firm's efforts to transform its image as a seller of laboratory test systems to that of a value-based solutions provider, Stefan Willemsen, CEO of BioMérieux Inc., the company's North American business, said in an interview.